UMIN000050985Recruiting
Exploratory prospective clinical study on predictors of efficacy of immune checkpoint inhibitors and immune-related adverse events in early-stage breast cancer
Showa universityNot ApplicableUniversity Hospital Medical Information Network
VerifiedUniversity Hospital Medical Information Network
Study focus
- Disease/Condition
- Breast cancer
- Study type
- Observational
Sponsor & location
- Primary sponsor
- Showa university
- Location
- Japan
Timeline & enrollment
- Phase
- Not Applicable
- Start date
- Apr 25, 2023
- End date
- N/A
ICD-10 classifications
Malignant neoplasm of breastMalignant neoplasm of breastCarcinoma in situ of breast, unspecifiedMalignant neoplasm: Breast, unspecifiedOther carcinoma in situ of breast
Data source
- Registry
- University Hospital Medical Information Network
- Trial ID
- UMIN000050985
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for UMIN000050985 through Pure Global AI's free database. This Not Applicable trial is sponsored by Showa university and is currently Recruiting. The study focuses on Breast cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.